Transcription of ESG Performance Summary 2020 - GSK
{{id}} {{{paragraph}}}
ESG Performance Summary 2020 March 2021 About this reportTrust is one of our three long-term priorities and is essential to how we achieve our purpose, drive long-term growth and add value for society and our have 13 commitments that support our Trust priority and drive progress in the key areas where we can make a significant impact, and ensure that we are running our business in a responsible way. These commitments seek to address the most material topics relevant to our stakeholders and to our business, and are designed to help us respond to challenges and opportunities within our industry and society more broadly. They contribute to many of the UN Sustainable Development Goals, and as a science-led, global healthcare company, our biggest contribution is towards Goal 3: ensure healthy lives and promote well-being for all at all statementSee page 32 of this document for the cautionary statement regarding forward-looking our reporting This
Modern Slavery Act Statement. 1 GSK ESG Performance Summary 2020 March 2021 Using our science and technology to employer address health needs ... 2015-19 2016-20 Change in net price (after discounts, rebates or other allowances) for our products in the US over the past 5 years. 3 – – -4.0%-3.2%
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}